Moderna (MRNA) said that the two-season Phase 3 study evaluating the efficacy, safety and immunogenicity of Moderna’s trivalent vaccine against ...

Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...

Earnings: Discover insights into revenue shifts, cost reductions, 2027 product goals, RSV market strategies, and its broader ...

Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 ...

Shares of Moderna, along with other vaccine makers, dropped further this year as lawmakers advanced President Donald Trump's ...

HSBC is preparing to report $1.5 billion of annual cost savings from the changes implemented under its broad restructuring ...

Revenue from COVID vaccine Comirnaty brought in sales of $3.38 billion, while antiviral treatment Paxlovid was $727 million ...

SiriusXM’s Megyn Kelly said Friday during her show that she would be watching Republican Louisiana Sen. Bill Cassidy’s vote ...

Maggie Hassan, a New Hampshire Democrat, confronted Robert F. Kennedy Jr. about his insistence on falsely linking vaccines to autism, saying the issue was a deeply personal one for her.

President Donald Trump’s pick for secretary of Health and Human Services said he will divest his interest in lawsuits against an HPV vaccine manufacturer. In written responses to questions from Sen.

WASHINGTON — Facing intense scrutiny from senators over his potential profit from vaccine lawsuits while serving as the nation's health secretary, Robert F. Kennedy Jr. said that if he is ...